The Voxel Group provides services in 3 synergistic
and complementary segments: diagnostics, therapeutics and IT.
Publication of the quarterly report for 3Q24
3Q24 results videoconference
Obtaining a permit for the construction of a production and office buildingRADIOFARM 4.0 a new intelligent radiopharmaceutical factoryby ALTERIS S.A
Submitting the CIT-10Z declaration for 2019, 2020 and 2022 and correction CIT-10Z declaration for 2021. Tax payment along with interest on tax arrears
Registration of changes to the statute of VOXEL S.A.
Technical correction of the report for the financial year 2023
Dismissal and appointment of a member of the Supervisory Board
Resolution on dividend payment adopted by the Ordinary General ShareholdersAssembly on June 28, 2024
Content of resolutions adopted at the Ordinary General Meetingon June 28, 2024
List of shareholders holding at least 5% of the votesOrdinary General Meeting on June 28, 2024.
Nomination of a candidate for a member of the Supervisory Board
Request to include items on the agenda and change the agenda meeting of the Ordinary General Meeting of VOXEL S.A. convened as of June 28, 2024
Draft resolutions and documents to be the subject of proceedings of the Ordinary General Meeting of VOXEL S.A. in day June 28, 2024
Announcement of convening the Ordinary General Meeting
Recommendation of the Company’s Management Board together with the opinion of the Supervisory Board on the payment of dividend
Submitting draft resolutions to the agenda of the next General Meeting.
Publication dates of periodic reports in the 2024 financial year
Information on transactions obtained pursuant to Art. 19 MAR
Information on transactions obtained pursuant to Art. 19 MAR
Information on transactions obtained pursuant to Art. 19 MAR
VOXEL S.A.
Ceglana St. 35, 40-514 Katowice
tel: +48 32 606 05 06
e-mail: relacje@voxel.pl
VOXEL S.A.
Ceglana St. 35, 40-514 Katowice
tel: +48 32 606 05 00
e-mail: biuro@voxel.pl
